Navigation Links
Healthcare Reform and Green Initiatives Trigger Explosive Growth in UV Disinfection Technologies
Date:7/14/2009

VALENCIA, Calif., July 14 /PRNewswire/ -- The healthcare industry is under attack from all sides. The Obama Administration has asked hospitals to give up $155 billion in future Medicare and Medicaid payments to fund healthcare reform, all the while operating and energy costs continue to rise; insurance providers pay later, pay less and demand more; patients are postponing (profitable) elective surgery; and fewer patients maintain adequate insurance coverage to pay for needed care. In the midst of this crisis, Lumalier Corporation, a U.S. manufacturer of advanced Ultraviolet Germicidal Disinfection Equipment, is experiencing unprecedented growth.

"Sales of Tru-D, a Total Room Disinfection Device, have increased over 250% this year," said Chuck Dunn, President and CEO of Lumalier. According to the manufacturer, Tru-D is an advanced, automated, mobile air and surface disinfection device. "Tru-D is more thorough than manual cleaning protocols and is automated to eliminate human error. It reduces chemical usage and provides fast disinfection of surfaces and air in the hospital environment," said Dunn. "Hospitals are able to reduce costs without reducing services and can turn over rooms more efficiently while insuring that new patients enter a clean and healthy environment."

That's good news to Hospital Administrators and Infection Control Practitioners challenged to provide increased patient care and efficient facility usage with ever-shrinking dollars. Independent Tru-D studies presented at the annual APIC conference (Association of Professionals in Infection Control and Epidemiology) were overwhelmingly favorable, verifying the manufacturer's claims, and creating a backlog of interest.

As a result of this growth, Lumalier announced the opening of a new West Coast office in Valencia, California. Katja Auer has been selected as Director of Business Development for Lumalier Corporation, and will manage the West Coast office. "Lumalier is very methodical in seeking out the best and brightest in our field of UV Disinfection. Katja is a highly qualified, respected professional within the UV industry," stated Dunn. "We look forward to the expertise and knowledge she will provide to our organization. She will be a major asset to our clients worldwide."

Ms. Auer holds a Bachelor's Degree in Chemistry from Connecticut State University, Master's Degree in Analytical Chemistry from the University of Arizona and an MBA from the University of LaVerne. She brings a remarkable diversity of experience in technical sales, management, ISO and FDA quality systems, product R&D, and customer support. She is a voting member and secretary of ASHRAE's TC2.9 Technical Committee on UV Air and Surface Disinfection, and is corresponding member and secretary of the ASHRAE SPC-185 Committee for developing methods of test standards for UV.

Lumalier Corporation is a leading manufacturer of UV germicidal air and surface disinfection equipment for healthcare, correctional, educational, government and private sectors. Lumalier produces a full line of UVC products for the commercial HVAC market, providing the key benefits of cleaner, healthier air, reductions in HVAC maintenance costs, and reductions in energy consumption.

Contact: Katja Auer at 818-679-6961; KatjaAuer@lumalier.com, or visit http://www.lumalier.com

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE Lumalier Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
11. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... San Jose, Calif (PRWEB) , ... July 26, 2017 , ... Six greater Bay Area ... save lives with “Make ‘em Bleed,” the most widely attended series of blood drives in ... 900 units of blood over the past 4 years -- enough to have helped to ...
(Date:7/26/2017)... ... ... It may be hard to imagine that the basic necessities that developed countries ... that many developed countries consider rare or eradicated, like measles, are still a rite ... an upcoming segment of "Success Files", actor Rob Lowe will introduce a new segment ...
(Date:7/26/2017)... ... July 27, 2017 , ... It's time to sign up for the ... great benefits," says Kathy Heshelow, founder of Sublime Naturals and author of numerous books on ... oil each month, mailed by the 5th. , Two items are included ...
(Date:7/26/2017)... ... ... “We are thrilled to be partnering with Six Month Smiles to work ... in real time,” said Keith English, LocalMed CEO. “Allowing patients the ability to schedule ... Month Smiles patients to their providers.” , Each month, over 25,000 patients research Six ...
(Date:7/26/2017)... ... 26, 2017 , ... Isodiol International Inc. (CSE: ISOL) (OTC: ... the development of pharmaceutical and consumer products, announces the operational numbers of its ... Iso International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/14/2017)... It should come as no surprise to anyone that ... of a crippling opioid epidemic. According to the Center ... deaths from opiate-based medications has quadrupled, Says, Dr. David ... 2001 to 2015". During this time, the prescription rate for ... a compelling link between prescription and eventual addiction. The problem ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
Breaking Medicine Technology: